Company Filing History:
Years Active: 2002
Title: The Innovations of William F. Lathrop
Introduction
William F. Lathrop is an accomplished inventor based in Plantsville, CT (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that interact with progesterone receptors. His work has implications for various therapeutic applications.
Latest Patents
Lathrop holds a patent for "Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents." This invention relates to 2-arylimino heterocycles, including 2-arylimino-1,3-thiazolidines, 2-arylimino-2,3,4,5-tetrahydro-1,3-thiazines, 2-arylimino-1,3-thiazolidin-4-ones, 2-arylimino-1,3-thiazolidin-5-ones, and 2-arylimino-1,3-oxazolidines. These compounds are designed to modulate progesterone receptor-mediated processes and are utilized in pharmaceutical compositions for therapeutic purposes. Lathrop has 1 patent to his name.
Career Highlights
William F. Lathrop is associated with Bayer Corporation, where he has contributed to innovative research and development in the pharmaceutical sector. His expertise in chemistry and pharmacology has enabled him to create valuable compounds that enhance therapeutic options for patients.
Collaborations
Lathrop has worked alongside notable colleagues, including Brian R. Dixon and Cedo Martin Bagi. Their collaborative efforts have further advanced the research and development of new pharmaceutical agents.
Conclusion
William F. Lathrop's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the development of therapies that improve health outcomes.